OpenURL Connection Search

Select item for more details and to access through your institution.

Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study.
Published in:
European Journal of Hybrid Imaging, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41824-023-00178-1
By:
- Murthy, Vishnu;
- Appiah-Kubi, Emmanuel;
- Nguyen, Kathleen;
- Thin, Pan;
- Hotta, Masatoshi;
- Shen, John;
- Drakaki, Alexandra;
- Rettig, Matthew;
- Gafita, Andrei;
- Calais, Jeremie;
- Sonni, Ida
Publication type:
Article
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.
Published in:
Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1737, doi. 10.2967/jnumed.122.265155
By:
- Murthy, Vishnu;
- Gafita, Andrei;
- Thin, Pan;
- Nguyen, Kathleen;
- Grogan, Tristan;
- Shen, John;
- Drakaki, Alexandra;
- Rettig, Matthew;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer.
Published in:
Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 869, doi. 10.2967/jnumed.122.264946
By:
- Gudenkauf, Lisa M.;
- Chavez, Melody N.;
- Maconi, Melinda Leigh;
- Geiss, Carley;
- Seyedroudbari, Ameen;
- Thin, Pan;
- Hoogland, Aasha I.;
- Nguyen, Kathleen;
- Murthy, Vishnu;
- Armstrong, Wesley R.;
- Komrokji, Khaled;
- Oswald, Laura B.;
- Jim, Heather S. L.;
- El-Haddad, Ghassan;
- Fendler, Wolfgang P.;
- Herrmann, Ken;
- Cella, David;
- Czernin, Johannes;
- Hofman, Michael S.;
- Dicker, Adam P.
Publication type:
Article
Safety of PSMA-targeted molecular radioligand therapy with 177Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262543
By:
- Calais, Jeremie;
- Czernin, Johannes;
- Thin, Pan;
- Gartmann, Jeannine;
- Nguyen, Kathleen;
- Armstrong, Wesley R;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan 5;
- Gardner, Linda;
- Dahlbom, Magnus;
- He, Beilei;
- Esfandiari, Rouzbeh;
- Ranganathan, David;
- Herrmann, Ken;
- Eiber, Matthias;
- Fendler, Wolfgang P.;
- Delpassand, Ebrahim
Publication type:
Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu- PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261982
By:
- Calais, Jeremie;
- Gafita, Andrei;
- Eiber, Matthias;
- Armstrong, Wesley R.;
- Gartmann, Jeannine;
- Thin, Pan;
- Nguyen, Kathleen;
- Lok, Vincent;
- Gosa, Laura;
- Grogan, Tristan;
- Esfandiari, Rouzbeh;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Ranganathan, David;
- Slavik, Roger;
- Dahlbom, Magnus;
- Herrmann, Ken
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Zhu, Shaojun;
- Thin, Pan;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261982
By:
- Calais, Jeremie;
- Gafita, Andrei;
- Eiber, Matthias;
- Armstrong, Wesley R;
- Gartmann, Jeannine;
- Thin, Pan;
- Nguyen, Kathleen;
- Lok, Vincent;
- Gosa, Laura;
- Grogan, Tristan;
- Esfandiari, Rouzbeh;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Ranganathan, David;
- Slavik, Roger;
- Dahlbom, Magnus;
- Herrmann, Ken
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Thin, Pan;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
Safety of PSMA-targeted molecular radioligand therapy with 177Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262543
By:
- Calais, Jeremie;
- Czernin, Johannes;
- Thin, Pan;
- Gartmann, Jeannine;
- Nguyen, Kathleen;
- Armstrong, Wesley R.;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Dahlbom, Magnus;
- Beilei He;
- Esfandiari, Rouzbeh;
- Ranganathan, David;
- Herrmann, Ken;
- Eiber, Matthias;
- Fendler, Wolfgang P.;
- Delpassand, Ebrahim
Publication type:
Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177LuPSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261982
By:
- Calais, Jeremie;
- Gafita, Andrei;
- Eiber, Matthias;
- Armstrong, Wesley R.;
- Gartmann, Jeannine;
- Thin, Pan;
- Nguyen, Kathleen;
- Lok, Vincent;
- Gosa, Laura;
- Grogan, Tristan;
- Esfandiari, Rouzbeh;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Ranganathan, David;
- Slavik, Roger;
- Dahlbom, Magnus;
- Herrmann, Ken
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Thin, Pan;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
Safety of PSMA-targeted molecular radioligand therapy with 177Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262543
By:
- Calais, Jeremie;
- Czernin, Johannes;
- Thin, Pan;
- Gartmann, Jeannine;
- Nguyen, Kathleen;
- Armstrong, Wesley R.;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Dahlbom, Magnus;
- Beilei He;
- Esfandiari, Rouzbeh;
- Ranganathan, David;
- Herrmann, Ken;
- Eiber, Matthias;
- Fendler, Wolfgang P.;
- Delpassand, Ebrahim
Publication type:
Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261982
By:
- Calais, Jeremie;
- Gafita, Andrei;
- Eiber, Matthias;
- Armstrong, Wesley R.;
- Gartmann, Jeannine;
- Thin, Pan;
- Nguyen, Kathleen;
- Lok, Vincent;
- Gosa, Laura;
- Grogan, Tristan;
- Esfandiari, Rouzbeh;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Ranganathan, David;
- Slavik, Roger;
- Dahlbom, Magnus;
- Herrmann, Ken
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Thin, Pan;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
Safety of PSMA-targeted molecular radioligand therapy with 177Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262543
By:
- Calais, Jeremie;
- Czernin, Johannes;
- Thin, Pan;
- Gartmann, Jeannine;
- Nguyen, Kathleen;
- Armstrong, Wesley R.;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Dahlbom, Magnus;
- Beilei He;
- Esfandiari, Rouzbeh;
- Ranganathan, David;
- Herrmann, Ken;
- Eiber, Matthias;
- Fendler, Wolfgang P.;
- Delpassand, Ebrahim
Publication type:
Article
Prospective phase 2 trial o _PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261982
By:
- Calais, Jeremie;
- Gafita, Andrei;
- Eiber, Matthias;
- Armstrong, Wesley R.;
- Gartmann, Jeannine;
- Pan Thin;
- Nguyen, Kathleen;
- Lok, Vincent;
- Gosa, Laura;
- Grogan, Tristan;
- Esfandiari, Rouzbeh;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Ranganathan, David;
- Slavik, Roger;
- Dahlbom, Magnus;
- Herrmann, Ken
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Thin, Pan;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu- PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.261982
By:
- Calais, Jeremie;
- Gafita, Andrei;
- Eiber, Matthias;
- Armstrong, Wesley R.;
- Gartmann, Jeannine;
- Thin, Pan;
- Nguyen, Kathleen;
- Lok, Vincent;
- Gosa, Laura;
- Grogan, Tristan;
- Esfandiari, Rouzbeh;
- Allen-Auerbach, Martin;
- Quon, Andrew;
- Bahri, Shadfar;
- Gupta, Pawan;
- Gardner, Linda;
- Ranganathan, David;
- Slavik, Roger;
- Dahlbom, Magnus;
- Herrmann, Ken
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Pan Thin;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Thin, Pan;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Pan Thin;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
The impact of monosodium glutamate on 68Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.257931
By:
- Armstrong, Wesley R.;
- Gafita, Andrei;
- Shaojun Zhu;
- Thin, Pan;
- Nguyen, Kathleen;
- Alano, Rejah;
- Lira, Stephanie;
- Booker, Kiara;
- Gardner, Linda;
- Grogan, Tristan;
- Elashoff, David;
- Allen-Auerbach, Martin;
- Dahlbom, Magnus;
- Czernin, Johannes;
- Calais, Jeremie
Publication type:
Article
Visual and whole-body quantitative analyses of 68 Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE.
Published in:
Annals of Nuclear Medicine, 2024, v. 38, n. 4, p. 296, doi. 10.1007/s12149-023-01899-w
By:
- Hotta, Masatoshi;
- Sonni, Ida;
- Thin, Pan;
- Nguyen, Kathleen;
- Gardner, Linda;
- Ciuca, Liliana;
- Hayrapetian, Artineh;
- Lewis, Meredith;
- Lubin, David;
- Allen-Auerbach, Martin
Publication type:
Article

Found: 23

Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study.

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.

Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer.

Safety of PSMA-targeted molecular radioligand therapy with <sup>177</sup>Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.

Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu- PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

Safety of PSMA-targeted molecular radioligand therapy with <sup>177</sup>Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.

Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177LuPSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

Safety of PSMA-targeted molecular radioligand therapy with <sup>177</sup>Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.

Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

Safety of PSMA-targeted molecular radioligand therapy with <sup>177</sup>Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.

Prospective phase 2 trial o _PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu- PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

The impact of monosodium glutamate on <sup>68</sup>Ga-PSMA-11 biodistribution in men with prostate cancer: a prospective randomized, controlled, imaging study.

Visual and whole-body quantitative analyses of <sup>68</sup> Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with <sup>177</sup>Lu-DOTATATE.